Maxwell Djordjevic

    Maxwell Djordjevic is a highly-regarded author and expert in the field of finance and stock exchanges. He graduated with a degree in Economics from Stanford University, supplementing his formal education with extensive self-study in financial markets. After his studies, he began his career at Goldman Sachs, contributing to their successful equity research division for over a decade before pursuing a full-time career in writing. Now, Maxwell applies his vast knowledge and experience to provide insightful commentary and analysis on financial markets, stock exchange, and shares. Each of his works reflects the depth of his understanding and his unique ability to simplify complex financial principles for readers at all levels. In his free time, Maxwell continues to advance his education, pursuing an MBA that further bolsters his status as an authority in his field.

    Rivian’s Stock: Is It the Tesla of Tomorrow?

    Rivian’s Stock: Is It the Tesla of Tomorrow?

    Rivian is seen as a potential disruptor in the electric vehicle (EV) market, with aspirations to rival Tesla. The company specializes in electric trucks and SUVs, targeting the adventure-ready vehicle segment. Strong investment backing from major players like Amazon and Ford strengthens
    1. March 2025
    Why Viking Therapeutics is Turning Heads Despite Financial Storms

    Why Viking Therapeutics is Turning Heads Despite Financial Storms

    Viking Therapeutics’ stock soared over 10% despite rising financial challenges, closing at $32.29. The surge was driven by optimism for VK2735, a potential breakthrough weight loss drug. The company exemplifies entrepreneurial resilience amid market volatility, drawing investor interest. Target price adjustments by
    25. February 2025

    Languages